Could a simple infusion make stroke recovery safer? new trial results are in.

NCT ID NCT04693715

Completed Disease control Sponsor: Revalesio Corporation Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated May 20, 2026 · Updated 15 times

Summary

This study tested the safety of an experimental drug called RNS60 in 83 people having a severe stroke caused by a large blood clot. Participants received either a low or high dose of RNS60 or a placebo (salt water) as a 48-hour IV drip, starting right before a procedure to remove the clot. The main goal was to see if RNS60 caused serious side effects, and researchers also tracked how many people were alive 90 days later.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE, ISCHEMIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Chattanooga Center for Neurologic Research

Chattanooga, Tennessee, 37404, United States
Houston Methodist Hospital

Houston, Texas, 77030, United States
Northwestern University

Chicago, Illinois, 60611, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States
Rhode Island Hospital

Providence, Rhode Island, 02903, United States
The Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Conditions

Explore the condition pages connected to this study.

STROKE, ISCHEMIC